Company: BNBX
Filing Date: 2025-11-10
Form Type: DEF 14A
Source: 0001104659-25-109257
Chunk: 37

Company: BNB PLUS CORP.
Filing Date: 2025-11-10
Form: DEF 14A
Chunk 37
---
 ​ | 368,654 | ​ | ​ | ​ | ​        | ​ | — | ​ | ​ | ​ | ​              | ​ | — | ​ | ​ | ​ | ​               | ​ | — | ​ | ​ | ​ | ​                                      | ​ | — | ​ | ​ | ​ |            ​ | ​ |      — | ​ | ​ | ​ |        ​ | ​ | 368,654 | ​ | ​ |
| ​                                                                            | ​ | ​ | 2024 | ​ |    ​ | ​ | ​ | ​ |   300,000 | ​ |       ​ | ​ | ​ | ​ | —        | ​ | ​ | ​ | ​ | ​ | —              | ​ | ​ | ​ | ​ | ​ | —               | ​ | ​ | ​ | ​ | ​ | —                                      | ​ | ​ | ​ | ​ | ​ |            — | ​ |      ​ | ​ | ​ | ​ |  300,000 | ​ |       ​ |   |   |

(1) Represents reimbursement payments to Dr. Hayward for costs associated with an automobile used by Dr. Hayward. (2) On December 13, 2024, Dr. Hayward stepped down as President of the Company and Ms. Murrah was appointed President of the Company. Also on December 13, 2024, Mr. Shorrock was named President of LRx. (3) On June 18, 2025 Dr. Hayward stepped down as CEO and Chairman on the Board and Ms. Murrah was appointed Chairperson of the Board and CEO. Dr. Hayward’s salary for fiscal 2025 includes the full $450,000 owed to him from his separation agreement. (4) On September 29, 2025 Ms. Murrah stepped down as CEO and President and Clay Shorrock was appointed as CEO and President. Ms. Murrah’s salary for fiscal 2025 includes the full $400,000 owed to her from her transition and separation agreement. On November 6, 2025, Ms. Murrah resigned as Chairperson of the Board and was replaced by Mr. Kruger. Ms. Murrah continues to serve as a director. (5) On October 17, 2025, Mr. Shorrock and Ms. Jantzen were each granted 18,691 RSUs, which vest 90 days from the date of grant. Base Salary We did not change the annual base salary for any